Agilent Technologies and North Carolina State University Collaborate to Develop New Microarray for Rice Disease Research.Business Editors/Science Writers/Health/Medical Writers BIOWIRE2K PALO ALTO Palo Alto, city, California Palo Alto (păl`ō ăl`tō), city (1990 pop. 55,900), Santa Clara co., W Calif.; inc. 1894. Although primarily residential, Palo Alto has aerospace, electronics, and advanced research industries. , Calif.--(BUSINESS WIRE)--April 23, 2003 Gene Expression Tool to Help Combat Agricultural Disease that Impacts Food Supply for 60 Million People Worldwide Agilent Technologies This article needs sources or references that appear in reliable, third-party publications. Alone, primary sources and sources affiliated with the subject of this article are not sufficient for an accurate encyclopedia article. Inc. (NYSE NYSE See: New York Stock Exchange :A) today announced a collaboration with North Carolina State University History
Rice blast (Magnaporthe grisea) is a filamentous filamentous /fil·a·men·tous/ (fil?ah-men´tus) composed of long, threadlike structures. filamentous composed of long, threadlike structures. fungus that causes rice blast disease, resulting in the loss of enough rice to feed 60 million people each year. Strains of this disease also attack wheat, barley and turf grasses. Besides causing significant economic damage, rice blast is a highly characterized organism that serves as a model for scientists studying filamentous fungi that cause other cereal and crop diseases. The sequencing of the rice blast genome was completed in July 2002. Research was paid for by a $1.7 million grant from the National Science Foundation and the U.S. Department of Agriculture's Microbial microbial pertaining to or emanating from a microbe. microbial digestion the breakdown of organic material, especially feedstuffs, by microbial organisms. Genome Sequencing Project. One of the principle investigators for the Rice Blast Functional Genomics Project was Ralph Dean, professor of Plant Pathology and director of the Fungal Genomics Laboratory at NCSU. "The goal of our research is to use the natural host resistance already present in some strains of rice as a defense against the rice blast pathogen," said Professor Dean. "We believe this new microarray will be of significant interest to the international agricultural community and are pleased to collaborate with Agilent in its development." "These microarrays are being designed to enable researchers to elucidate the molecular basis of plant disease, including the identification of host-pathogen interactions and the molecular pathways involved," said Barney Saunders, general manager and vice president of Agilent BioResearch bi·o·re·search n. Research in the biological sciences. Solutions unit. "We expect that this will be the first commercially available full-genome Magnaporthe microarray as well as a first of its kind." More information about Agilent's gene expression solutions and new Agbiotech program can be found at www.agilent.com/chem/DNA and www.agilent.com/chem/agbiotech, respectively. More information about rice blast and the fungal genomics project at NCSU is available at www.riceblast.org and www.fungalgenomics.ncsu.edu. Availability Agilent will be formulating a pre-launch interest list for this product. All interested parties are invited to register for upcoming information about this product by sending an e-mail to dna_microarrays@agilent.com. About Agilent Technologies Agilent Technologies Inc. (NYSE:A) is a global technology leader in communications, electronics, life sciences and chemical analysis. The company's 35,000 employees serve customers in more than 110 countries. Agilent had net revenue of $6 billion in fiscal year 2002. Information about Agilent is available on the Web at www.agilent.com. Forward-Looking Statements This news release contains forward-looking statements (including, without limitation, statements relating to Agilent's expectation that it will develop the first commercially available full-genome Magnaporthe microarray) that involve risks and uncertainties that could cause results of Agilent Technologies to differ materially from management's current expectations. These risks are detailed in the company's filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K Form 10-K A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information. Form 10-K See 10-K. for the year ended Oct. 31, 2002; its Current Report on Form 8-K Form 8-K The form required by the SEC when a publicly held company incurs any event that might affect its financial situation or the share value of its stock. Form 8-K See 8-K. dated Jan. 24, 2003; and its Current Report on Form 8-K dated Feb. 10, 2003. The company assumes no obligation to update the information in this press release. NOTE TO EDITORS: Press releases, photography and other information can be accessed on the Agilent Life Sciences and Chemical Analysis newsroom at www.agilent.com/about/newsroom/lsca. Further technology, corporate citizenship Corporate Citizenship The extent to which businesses are socially responsible in meeting legal, ethical and economic responsibilities placed on them by shareholders. The aim it to create higher standards of living and quality of life in the community in which it operates, while and executive news is available on the Agilent news site at www.agilent.com/go/news. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion